Antiretrovirals
Showing 1 - 25 of 348
Hiv Trial (Doravirine 100Mg Tab, Raltegravir 600Mg Tab, Biktarvy 50/200/25 Tab)
Not yet recruiting
- Hiv
- Doravirine 100Mg Tab
- +2 more
- (no location specified)
Dec 15, 2022
Implementing Long-Acting Novel Antiretrovirals
Recruiting
- Human Immunodeficiency Viruses
- The Feasibility of Intervention Measure (FIM) and Acceptability of Intervention Measure (AIM)
-
Brighton, United Kingdom
- +5 more
Sep 8, 2022
IV Drug Usage, HIV, Hepatitis C Trial in Miami, Tampa (Tele-Harm Reduction, off-site linkage)
Not yet recruiting
- IV Drug Usage
- +2 more
- Tele-Harm Reduction
- off-site linkage
-
Miami, Florida
- +1 more
Aug 9, 2022
HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)
Recruiting
- HIV-1-infection
-
Kisumu, Kenya
- +6 more
Feb 1, 2023
Continuum for Youth at HIV Risk, Acutely Infected and With
Active, not recruiting
- Human Immunodeficiency Virus
- Antiretrovirals
-
Los Angeles, California
- +2 more
Oct 24, 2022
HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)
Recruiting
- HIV I Infection
- +2 more
- Doravirine 100 Mg
-
Los Angeles, California
- +1 more
Nov 1, 2022
HIV, Contraception, Drug-drug Interaction Trial in Eldoret (Cabotegravir/ Rilpivirine, Etonogestrel (ETG) implant, Intramuscular
Recruiting
- HIV Infections
- +2 more
- Cabotegravir/ Rilpivirine
- +4 more
-
Eldoret, KenyaAcademic Model Providing Access to Healthcare (AMPATH) Moi Teach
Mar 30, 2022
HIV Trial run by the NIAID (Interleukin-2)
Completed
- HIV Infections
-
Bethesda, MarylandNIH Intramural Research Program ACTG CRS
Oct 28, 2021
Hiv Trial in Thailand (In-depth interviews (IDI), Focus group discussion (FGD))
Not yet recruiting
- Hiv
- In-depth interviews (IDI)
- Focus group discussion (FGD)
-
Bangkok, Bangkapi, Thailand
- +11 more
Mar 7, 2023
Pregnancy, Anti-integrase and Lymphocyte Repertoire of Newborn
Completed
- Anti-integrases
- Blood test
-
Colombes, France
- +4 more
Sep 22, 2021
HIV Prevention, Transgender Health Trial in San Francisco (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate)
Completed
- HIV Prevention
- Transgender Health
- 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate
-
San Francisco, CaliforniaSan Francisco AIDS foundation
Apr 16, 2021
oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt
Not yet recruiting
- HIV-1-infection
- Therapeutic drug monitoring in plasma of mother and child and in breastmilk
- (no location specified)
Nov 29, 2022
HIV Trial in Ciudad de Buenos Aires (Aldesleukin)
Completed
- HIV Infections
-
Ciudad de Buenos Aires, Buenos Aires, Argentina
- +3 more
Oct 27, 2021
Cost-effectiveness of Safer Conception Strategies for
Completed
- HIV Infections
- PrEP (Truvada)
- +3 more
-
Harare, ZimbabweUZCHS-UCSF CTRC Zengeza Clinical Research Site
Sep 27, 2019
HIV Trial in Paris (pulmonary function tests)
Completed
- HIV
- pulmonary function tests
-
Paris, FranceRobert Debre Hospital
May 11, 2023
Antiretroviral Agents in HIV-infected Pregnant Women.
Recruiting
- HIV Infections
-
Brussels, Belgium
- +20 more
Nov 28, 2022
Dolutegravir Trial in Johannesburg (CHARACTERISE)
Enrolling by invitation
- Dolutegravir
- CHARACTERISE
-
Johannesburg, Gauteng, South AfricaSunnyside Office Park
Aug 12, 2022
HIV Trial in London (Aldesleukin)
Completed
- HIV Infections
-
London, United KingdomKobler Ctr. of Chelsea Westminster Hosp. C604-030 CRS
Oct 27, 2021
Entry and Continuation in Care for People Living With HIV in
Recruiting
- Human Immunodeficiency Virus
- quetionnaire
-
Cayenne, France, French GuianaCentre Hospitalier de Cayenne
Apr 28, 2022